ArticleJAMA network open2026
Electronic Health Record Monitoring Dashboard and Developmental Screening in Pediatric Patients.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Early identification of developmental delay and autism in young children improves outcomes, but screening rates in young children are low, particularly for some patient groups. Objective: To examine patient- and system-level characteristics associated with screening return rates and timelines and evaluate the association of an electronic health record (EHR)-based dashboard with these outcomes. Design, Setting, Participants: This retrospective cohort study using EHR data from a large integrated health care system analyzed screening questionnaire return rates and time to return among children aged 6 to 66 months referred to a secondary screening program. A cross-sectional analysis (September 1, 2022, to September 1, 2023) used adjusted modified Poisson regression and restricted mean survival time (RMST). Changes in return rates, as well as time to return and time to case completion, were assessed before (November 2, 2022, to March 31, 2023) and after (November 2, 2023, to March 31, 2024) implementation of an EHR-embedded monitoring dashboard. Data were analyzed from December 5, 2023, to February 20, 2026. Exposures: Patient and organizational characteristics based on EHR data and indicators for dashboard implementation. Main Outcomes and Measures: Return rates of screening questionnaires, time to return questionnaires in days, and time to case completion in days (review questionnaire, recommendations to families, and place relevant referrals). Results: A total of 17 303 screening referral orders (11 351 [65.6%] among males; mean [SD] age, 27.73 [12.79] months; 15 853 [91.6%] aged 16-66 months) for 16 038 unique patients were included in this study. Questionnaires were returned for 7500 referrals (43.3%). Lower return rates were associated with older age (adjusted relative risk [ARR], 0.71 [95% CI, 0.68-0.75]), non-English language preference (ARR range, 0.65 [95% CI, 0.47-0.89] to 0.73 [95% CI, 0.65-0.83]), Black race (ARR, 0.79 [95% CI, 0.72-0.86]) or Hispanic ethnicity (ARR, 0.85 [95% CI, 0.81-0.89]), highest neighborhood deprivation quintile (ARR, 0.92 [95% CI, 0.86-0.98]), and Medicaid insurance (ARR, 0.85 [95% CI, 0.81-0.89]). Online portal account access was linked to higher return rates (ARR, 1.99 [95% CI, 1.75-2.26]) and faster return times (adjusted RMST difference, -6.42 days [95% CI, -7.26 to -5.59 days]). Older age was associated with longer return times (adjusted RMST difference, 6.82 days [95% CI, 5.90-7.75 days]). After dashboard implementation, return rates increased from 41.2% (2823 of 6854) to 54.7% (3883 of 7097) (ARR, 1.34 [95% CI, 1.29-1.38]), while decreases were observed for time to return (adjusted RMST difference, -6.62 days [95% CI, -7.18 to -6.07 days]) and completion (adjusted RMST difference, -37.07 days [95% CI, -38.47 to -35.67] days). Conclusions and Relevance: The findings of this cohort study suggest that completion of recommended developmental screening can be challenging for certain patient populations. EHR-based tools may be useful to improve return rates and reduce return and case completion times.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.